Position in FOLD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$84,502,056
+$56,262,584 QoQ
Shares Held
5,843,849
+194.7% QoQ
Ownership
1.86%
of shares outstanding
% of Portfolio
1.80%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FOLD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AQR Arbitrage LLC holds $185,136,566 across 7 Biotechnology names. FOLD ranks #1 (45.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | FOLD |
AMICUS THERAPEUTICS, INC.
This page
|
5,843,849 | $84,502,056 | |
| 2 | DAWN |
Day One Biopharmaceuticals, Inc.
|
2,462,154 | $52,788,581 | |
| 3 | ACLX |
Arcellx, Inc.
|
231,730 | $26,607,238 | |
| 4 | TERN |
Terns Pharmaceuticals, Inc.
|
171,555 | $9,044,379 | |
| 5 | APLS |
Apellis Pharmaceuticals, Inc.
|
146,604 | $5,897,878 | |
| 6 | CNTA |
Centessa Pharmaceuticals plc
|
98,028 | $3,893,672 | |
| 7 | RNA |
Atrium Therapeutics, Inc.
|
179,713 | $2,402,762 |
All Filings in FOLD
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $84,502,056 | 5,843,849 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $28,239,472 | 1,983,109 | Shares | Defined | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||